Functional and biochemical characterization of a novel human macrophage-derived negative regulator of haematopoiesis

Cytokine

Volumn 11, Issue 12, 1999, Pages 985-995

  Dialynas, Deno P ^a   Shao, Li En ^a   Hinojosa, Alejandro G ^a   Yu, John ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cell cycling; Chemoprotectant; Haematopoiesis; Macrophage; Negative regulation

Indexed keywords

HEPARIN BINDING PROTEIN;

ARTICLE; BIOCHEMISTRY; CELL CYCLE; CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HYDROPHOBICITY; MACROPHAGE; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PURIFICATION; STEM CELL;

MYCOBACTERIUM AVIUM COMPLEX (MAC);

EID: 0033368828     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0507     Document Type: Article

References (32)

1. Axelrad AA. Some hemopoietic negative regulators. Exp Hematol. 18:1990;143-150.
2. Anagnostou A, Dainiak N, Najman A. Positive news on the negative growth factors. Ann NY Acad Sci. 628:1991;1-7.
3. Yu J. Regulation and reconstitution of human hematopoiesis. J Formos Med Assoc. 95:1996;281-293.
4. Dalmau SR, Freitas CS, Savino W. Radio- and chemoprotection of bone marrow cells by opposite cell cycle-acting cytokines. Leuk Res. 21:1997;93-99.
5. Ruscetti FW, Jacobsen SE, Birchenall-Roberts M, Broxmeyer HE, Engelmann GL, Dubois C, Keller JR. Role of transforming growth factor-β1 in regulation of hematopoiesis. Ann NY Acad Sci. 628:1991;31-43.
6. Sargiacomo M, Valtieri M, Gabbianelli M, Pelosi E, Testa U, Camagna A, Peschle C. Pure human hematopoietic progenitors: Direct inhibitory effect of transforming growth factors-β1 and β2. Ann NY Acad Sci. 628:1991;84-91.
7. Graham GJ, Wright EG, Hewick R, Wolpe SD, Wilkie NM, Donaldson D, Lorimore S, Pragnell IB. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature. 344:1990;442-444.
8. Miller MD, Krangel MS. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol. 12:1992;17-46.
9. Taub DD, Oppenheim JJ. Chemokines, inflammation and the immune system. Ther Immunol. 1:1994;229-246.
10. Rollins BJ. Chemokines. Blood. 90:1997;909-928.
11. Roodman GD, Bird A, Hutzler D, Montogmery W. Tumor necrosis factor-alpha and hematopoietic progenitors: Effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. Exp Hematol. 15:1987;928-935.
12. Billiau A. Interferon-γ.: Biology and role in pathogenesis. Adv Immunol. 62:1996;61-130.
13. Bogden AE, Carde P, Deschamps de Paillette E, Moreau J-P, Tubiana M, Frindel E. Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation. Ann NY Acad Sci. 628:1991;126-139.
14. Paukovits WR, Moser M-H, Rutter R, Paukovits JB. Inhibition of hematopoietic stem cell proliferation by hemoregulatory peptide pyroGlu-Glu-Asp-Cys-Lys (pEEDCK) provides protection against short-term neutropenia and long-term damage. Ann NY Acad Sci. 628:1991;92-104.
15. Dialynas DP, Tan PC, Huhn GD, Yu J. Characterization of a new human macrophage cell line 2MAC: 1. Expression of functional macrophage CD16 (FcγRIIIA/γ) and tissue factor induction on ligation of HLA-DR. Cell Immunol. 177:1997;182-193.
16. Broxmeyer HE, Sherry B, Cooper S, Lu L, Maze R, Beckmann MP, Cerami A, Ralph P. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. J Immunol. 150:1993;3448-3458.
17. ITmarrow negatively regulates DNA synthesis in erythropoietic progenitor cells BFU-E. Cell. 26:1981;233-244.
18. McNiece IK, Stewart FM, Deacon DM, Temeles DS, Zsebo KM, Clark SC, Quesenberry PJ. Detection of a human CFC with a high proliferative potential. Blood. 74:1989;609-612.
19. McNiece IK, Bertoncello I, Kriegler AB, Quesenberry PJ. Colony-forming cells with high proliferative potential (HPP-CFC). Int J Cell Cloning. 8:1990;146-160.
20. Eaves CJ, Cashman JD, Eaves AC. Methodology of long-term culture of human hemopoietic cells. J Tissue Culture Methods on Stem Cell Biol. 13:1991;55-62.
21. Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM. Characterization and partial purification of human marrow cells capable of initiating lone-term hematopoiesis in vitro. Blood. 74:1989;1563-1570.
22. Cashman JD, Eaves AC, Raines EW, Ross R, Eaves CJ. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-β Blood. 75:1990;96-101.
23. Cashman J, Eaves AC, Eaves CJ. Regulated proliferation of primitive hematopoietic progenitor cells in long-term human marrow cultures. Blood. 66:1985;1002-1005.
24. Sarris AH, Broxmeyer HE, Wirthmueller U, Karasavvas N, Cooper S, Lu L, Krueger J, Ravetch JV. Human interferon-inducible protein 10: Expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors. J Exp Med. 178:1993;1127-1132.
25. Cashman J, Eaves A, Sarris A, Eaves C. Evidence for a novel inhibitor acting in normal longterm human marrow cultures, induced by AcSDKP and inactive on primitive CML progenitors. Blood. 84:1994;277a.
26. Eaves CJ, Cashman JD, Wolpe SD, Eaves AC. Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein-1α (MIP-1α) an inhibitor of primitive normal hematopoietic cells. Proc Natl Acad Sci U S A. 90:1993;12 015-12 019.
27. 2+mobilization in response to ligation of macrophage HLA-DP. J Interferon Cytokine Res. 17:1997;671-679.
28. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest. 97:1968;77-109.
29. Yu J, Shao L-E, Vaughan J, Vale W, Yu AL. Characterization of the potentiation effect of activin on human erythroid colony formation in vitro. Blood. 73:1989;952-960.
30. Lane TA, Law P, Maruyama M, Young D, Burgess J, Mullen M, Mealiffe M, Terstappen LWMM, Hardwick A, Moubayed M, Oldhame F, Corringham RET, Ho AD. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: Potential role in allogeneic marrow transplantation. Blood. 85:1995;275-282.
31. Iscove NN, Sieber F, Winterhalter KH. Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A. J Cell Physiol. 83:1974;309-320.
32. Eaves AC, Cashman JD, Gaboury LA, Eaves CJ. Clinical significance of long-term cultures of myeloid blood cells. CRC Crit Rev Oncol Hematol. 7:1987;125-138.